The Icahn School of Medicine at Mount Sinai launched the AI Small Molecule Drug Discovery Center which was created to integrate AI with traditional drug discovery methods to identify and design new ...
New York City (Oct 3, 2024) - Researchers from the Icahn School of Medicine at Mount Sinai have introduced KiNet, an interactive web portal designed to explore kinase-substrate interactions in human ...
1d
Mount Sinai Health System CEO Named to Modern Healthcare’s 100 Most Influential People in Healthcare
“Influence can be exerted in many ways, but when it is used to improve health care delivery and outcomes, patients and professionals alike benefit,” said Mary Ellen Podmolik, Editor-in-Chief of Modern ...
In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and ...
Mount Sinai scientists developed V2P, a powerful new AI tool that predicts how specific DNA mutations translate into disease, unlocking faster diagnoses and new targets for therapy.
The Mount Sinai Health System has received an $8 million grant from DataPhilanthropy to fuel urgently needed research into CADASIL, a genetic disease associated with changes to small blood vessels ...
Researchers at the Icahn School of Medicine at Mount Sinai say they have made a new discovery about how human cells make RNA, a molecule that functions as a set of blueprints that tell cells how to ...
The parents of 7-week-old Dhruvan Gopi were warned he might not survive the night as specialists converged around his crib at ...
New York, NY, April 02, 2025 (GLOBE NEWSWIRE) -- The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback